Marker Therapeutics MRKR
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 0.89 | 18 | -13.84 | -2 | -10.95 | 22 |
| 2025Q2 | 1.53 | 10 | -32.15 | -4 | -25.29 | 15 |
| 2025Q1 | 1.23 | 14 | -26.90 | -4 | -22.79 | 17 |
| 2024Q4 | 3.11 | 19 | -29.51 | -4 | -23.31 | 22 |
| 2024Q3 | 2.82 | 7 | -26.91 | -2 | -20.44 | 11 |
| 2024Q2 | 5.43 | 10 | -20.41 | -2 | -17.02 | 12 |
| 2024Q1 | 4.30 | 12 | -18.52 | -2 | -15.33 | 14 |
| 2023Q4 | 5.50 | 14 | -18.22 | -3 | -15.31 | 17 |
| 2023Q3 | 4.54 | 17 | -16.69 | -3 | -14.39 | 19 |
| 2023Q2 | 3.10 | 19 | 14.40 | 3 | 10.08 | 22 |
| 2023Q1 | 0.71 | 16 | -27.98 | -5 | -15.93 | 28 |
| 2022Q4 | 2.66 | 20 | -18.27 | -4 | -10.21 | 34 |
| 2022Q3 | 3.69 | 23 | -27.34 | -7 | -14.81 | 41 |
| 2022Q2 | 3.30 | 28 | -29.01 | -9 | -17.23 | 52 |
| 2022Q1 | 4.40 | 36 | -24.87 | -10 | -16.10 | 55 |
| 2021Q4 | 9.50 | 44 | -20.28 | -10 | -13.94 | 68 |
| 2021Q3 | 16.90 | 52 | -21.52 | -12 | -16.31 | 72 |
| 2021Q2 | 27.90 | 63 | -16.07 | -11 | -12.92 | 80 |
| 2021Q1 | 22.40 | 72 | -17.59 | -9 | -13.11 | 88 |
| 2020Q4 | 14.50 | 27 | -29.36 | -9 | -18.06 | 46 |